Experimental drug shows promise as multiple sclerosis treatment

An experimental drug reduces brain atrophy in people with progressive multiple sclerosis, raising hopes that it also can reduce disability.
View Content

People with a progressive form of multiple sclerosis (MS) face a gradual decline of brain function that slowly strips away the ability to walk and may cause problems with speech and vision. Available treatments are only modestly effective at slowing the decline.